Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
Background Clinical trials in cystic fibrosis (CF) have been hindered by the paucity of well
characterised and clinically relevant outcome measures. Aim To evaluate a range of …
characterised and clinically relevant outcome measures. Aim To evaluate a range of …